Monograph

A02BB01 - Misoprostol

Propably not porphyrinogenic

Rationale

Prostaglandin. Probably only insignificant hepatic exposure.

Chemical description

Tablets; 0.2-0.8 mg/d. Synthetic prostaglandin, which is inhibitor of ventricular secretion. Mucosaprotective effect against ASA induced ventricular lesions. Metabolized in several organs by beta-omega oxidation. Misoprostol and misoprostolic acid is excrered by the kidneys and faeces as various metabolites. South African list: use with extreme caution only. French list: authorized

IPNet drug reports

Uneventful use reported in 2 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes A02B / A02BB or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands